Indeloxazine

From WikiMD.org
Jump to navigation Jump to search

Indeloxazine

Indeloxazine (pronounced in-del-ox-a-zine) is a pharmacological agent that was primarily used in Japan for the treatment of cerebrovascular disorders and related conditions. It was developed by Yamanouchi Pharmaceutical Co. and marketed under the brand name Elen]].

Etymology

The term "Indeloxazine" is derived from the chemical structure of the compound, which is an indole derivative with an oxazine ring.

Pharmacology

Indeloxazine is classified as a serotonin-norepinephrine reuptake inhibitor (SNRI), which means it increases the levels of serotonin and norepinephrine in the brain by inhibiting their reuptake into neurons. It also has neuroprotective and nootropic effects, which are thought to be due to its ability to enhance cerebral blood flow and oxygen supply.

Medical Uses

Indeloxazine was primarily used for the treatment of cerebrovascular disease, including stroke and transient ischemic attack (TIA). It was also used for the management of dementia and other cognitive disorders, as well as for the treatment of depression and anxiety disorders.

Related Terms

See Also

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski